Potential of lansoprazole as a novel probe for cytochrome P450 3A activity by measuring lansoprazole sulfone in human liver microsomes

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 8, 2009, Pages 1422-1426

  Yanagida, Yohei ^a   Watanabe, Minoru ^a   Takeba, Yuko ^a   Kumai, Toshio ^a   Matsumoto, Naoki ^a   Hayashi, Mikihito ^a   Suzuki, Satoshi ^b   Kinoshita, Yuichi ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ichikawa General Hospital   (Japan)

Author keywords

Cytochrome P450 3A; Lansoprazole; Lansoprazole sulfone; Liver microsome

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; LANSOPRAZOLE;

ARTICLE; DRUG METABOLISM; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROXYLATION; INCUBATION TIME; LIVER MICROSOME; SULFOXIDATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTIBODIES, MONOCLONAL; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; METABOLIC DETOXICATION, PHASE I; MICROSOMES, LIVER; MOLECULAR PROBES; STEROID HYDROXYLASES; SULFONES;

EID: 69149103193     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1422     Document Type: Article

References (29)

1. Li A. P., Kaminski D. L., Rasmussen A., Toxicology, 104, 1-8 (1995).
2. Benet L. Z., Kroetz D. L., Sheiner L. B., "Goodman and Gilman's The Pharmacological Basis of Therapeutics," 9th ed., McGraw-Hill, New York, 1996.
3. Wacher V. J., Wu C. Y., Benet L. Z., Mol. Carcinog., 13, 129-134 (1995).
4. Zhou-Pan X. R., Sérée E., Zhou X. J., Placidi M., Maurel P., Barra Y., Rahmani R., Cancer Res., 53, 5121-5126 (1993).
5. Kostrubsky V. E., Lewis L. D., Strom S. C., Wood S. G., Schuetz E. G., Schuetz J. D., Sinclair P. R., Wrighton S. A., Sinclair J. F., Arch. Biochem. Biophys., 355, 131-136 (1998).
6. Dodds H. M., Haaz M. C., Riou J. F., Robert J., Rivory L. P., J. Pharmacol. Exp. Ther., 286, 578-583 (1998).
7. Wilkinson G. R., N. Engl. J. Med., 352, 2211-2221 (2005).
8. Schellens J. H., Soons P. A., Breimer D. D., Biochem. Pharmacol., 37, 2507-2510 (1998).
9. Bodmer M., Link B., Grignaschi N., Kummer O., Ruegg S., Haschke M., Krähenbühl S., Ther. Drug Monit., 30, 120-124 (2008).
10. Kim J. S., Nafziger A. N., Tsunoda S. M., Choo E. E., Streetman D. S., Kashuba A. D., Kulawy R. W., Beck D. J., Rocci M. L. Jr., Wilkinson G. R., Greenblatt D. J., Bertino J. S. Jr., J. Clin. Pharmacol., 42, 376-382 (2002).
11. Rais N., Chawla Y. K., Kohli K. K., Eur. J. Clin. Pharmacol., 62, 417-422 (2006).
12. Watkins P. B., Pharmacogenetics, 4, 171-184 (1994).
13. Pichard L., Curi-Pedrosa R., Bonfils C., Jacqz-Aigrain E., Domergue J., Joyeux H., Cosme J., Guengerich F. P., Maurel P., Mol. Pharmacol., 47, 410-418 (1995).
14. Masa K., Hamada A., Arimori K., Fujii J., Nakano M., Biol. Pharm. Bull., 24, 274-277 (2001).
15. Miura M., Tada H., Yasui-Furukori N., Uno T., Sugawara K., Tateishi T., Suzuki T., Eur. J. Clin. Pharmacol., 60, 623-628 (2004).
16. Pearce R. E., Rodrigues A. D., Goldstein J. A., Parkinson A., J. Pharmacol. Exp. Ther., 277, 805-816 (1996).
17. Niwa T., Kaneko H., Naritomi Y., Togawa A., Shiraga T., Iwasaki K., Tozuka Z., Hata T., Xenobiotica, 25, 1041-1049 (1995).
18. Ikeda T., Nishimura K., Taniguchi T., Yoshimura T., Hata T., Kashiyama E., Kudo S., Miyamoto G., Kobayashi H., Kobayashi S., Okazaki O, Hakusui H., Aoyama E., Yoshimura Y., Yamada Y., Yoshikawa M., Otsuka M., Niwa T., Kagayama A., Suzuki S., Sato T., Xenobiot. Metab. Dispos., 16, 115-126 (2001).
19. Suzuki S., Satoh T., Yoshino H., Kobayashi E., Life Sci., 76, 39-46 (2004).
20. Watanabe M., Kumai T., Matsumoto N., Tanaka M., Suzuki S., Satoh T., Kobayashi S., J. Pharmacol. Sci., 94, 459-462 (2004).
21. Chiou W. L., Jeong H. Y., Wu T. C., Ma C., Clin. Pharmacol. Ther., 70, 305-310 (2001).
22. Chen Y. C., Gotzkowsky S. K., Nafziger A. N., Kulawy R. W., Rocci M. L. Jr., Bertino J. S. Jr., Kashuba A. D., Br. J. Clin. Pharmacol., 62, 187-195 (2006).
23. Kita T., Sakaeda T., Baba T., Aoyama N., Kakumoto M., Kurimoto Y., Kawahara Y., Okamura N., Kirita S., Kasuga M., Okumura K., Biol. Pharm. Bull., 26, 386-390 (2003).
24. Böttiger Y., Eur. J. Clin. Pharmacol., 62, 621-625 (2006).
25. Andersson T., Miners J. O., Veronese M. E., Tassaneeyakul W., Tassaneeyakul W., Meyer U. A., Birkett D. J., Br. J. Clin. Pharmacol., 36, 521-530 (1993).
26. Kim K. A., Kim M. J., Park J. Y., Shon J. H., Yoon Y. R., Lee S. S., Liu K. H., Chun J. H., Hyun M. H., Shin J. G., Drug Metab. Dispos., 31, 1227-1234 (2003).
27. Waxman D. J., Attisano C., Guengerich F. P., Arch. Biochem. Biophys., 263, 424-436 (1998).
28. Yanagida Y., Takeba Y., Kumai T., Watanabe M., Matsumoto N., Hayashi M., Kobayashi S., St. Mariannna Med. J., 36, 313-322 (2008).
29. Pauli-Magnus C., Rekersbrink S., Klotz U., Fromm M. F., Naunyn-Schmiedeberg's Arch. Pharmacol., 364, 551-557 (2001).